img

A Living Biobank Of Ovarian Cancer – A Model For Drug Discovery

Synthetic lethality is a circumstance in which a drug is selectively deadly to cancer cells due to the mutations and genetic changes that have occurred during oncogenesis and progression. Oftentimes a cancer will lose redundancy, that is it will jettison certain survival/...

A Living Biobank Of Non-Small Cell Lung Cancer Organoids

Globally, cancer of the lung is the most common cause of cancer related mortality. It is also the most commonly diagnosed. 3D patient derived organoids provide a more faithful model of cancer than 2D in vitro cell culture and represent a model...

The Swedish p53 Study (SWEP53) With Biobank Option

The Swedish p53 Study (SWEP53) is a germ line TP53 pathogenic variant patient registry with three optional parts: a biobank, a surveillance program and a psychosocial evaluation of the surveillance. The full study outline was published in the journal...

The Chilean Biobanking Network – Predictive, Personalized, Preventive, Participatory

An article was recently published in the Medical Review of Chile with senior author María Elena Cabrera of El Salvador Hospital, Santiago, about the potential for developing a biobanking network within the country. According to the authors Chile has a unique...

The Gift Of Life Marrow Registry To Receive Advocacy Award At World Stem Cell...

The formal ceremony of the 2020 Stem Cell and Regenerative Medicine Action Awards will take place at a gala reception and dinner on January 23, during the 15th annual World Stem Cell Summit (WSCS) at the Hyatt Regency in...

Australia’s Great Barrier Reef Living Coral Biobank

As coral reefs worldwide decline due to climate change, severe storm events and coral disease, Australian non-profit organisation GBR Legacy, with partners Corals of the World and Cairns Marine, will safeguard the biodiversity of all known hard coral species by creating the...

Over 250,000 Participants Now Enrolled In Geisinger’s MyCode Precision Medicine Project

Geisinger’s groundbreaking precision medicine project, MyCode, has enrolled more than 250,000 participants in Pennsylvania and New Jersey, reaching a major landmark in the project. With DNA sequence and health data currently available on 145,000 of these participants, MyCode is the largest study of...

Kazan Federal University’s Extreme Biology Lab To Biobank Endangered Bird Species

Kazan Federal University’s Extreme Biology Lab has obtained grant funding with colleagues from Japan and Thailand. The support is provided by the Russian Foundation for Basic Research and the Science and Innovation in East Asia Consortium. Kazan Federal University’s partners are Mahidol University...

ImmunoQure And Memo Therapeutics Collaborate To Biobank Rare Disease Autoantibodies

ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases and Memo Therapeutics AG, a biotechnology company focused on the discovery and development of therapeutic antibodies from cognate paired antibody libraries have established a collaborative partnership...

CureDuchenne Launches Duchenne Muscular Dystrophy Biobank

CureDuchenne, a global leader in research, patient care, and innovation in improving and extending the lives of those living with Duchenne muscular dystrophy (Duchenne), has initiated the development of a biobank for Duchenne in partnership with University of California, Irvine (UCI) and...

⭐ Recently Featured

🔥 Popular Posts

X